The agreement will accelerate the development of Pfizer's chimeric antigen receptor T cell (CAR T) therapy, an investigational immune cell therapy for treating cancer."Pfizer signs deal with Allogene to develop cancer cell therapy" via FOX BIZ https://ift.tt/2GRTbho
No comments:
Post a Comment